Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-10-23-Speech-2-463-000"

PredicateValue (sorted: default)
rdf:type
dcterms:Date
dcterms:Is Part Of
dcterms:Language
lpv:document identification number
"en.20121023.45.2-463-000"2
lpv:hasSubsequent
lpv:speaker
lpv:spokenAs
lpv:translated text
"I voted in favour of granting the discharge to the European Medicines Agency in order to acknowledge the measures implemented by the Agency since the postponement of the discharge last May. The Agency has shown a commitment to addressing the concerns raised by the European Parliament. I commend in particular the efforts made by the Executive Director and his team to foster the Agency’s transparency towards European citizens through, for example, its commitment to developing public access to clinical trial data. I also welcome the its commitment to improving the prevention and management of conflicts of interest with systematic ex-ante and ex-post controls related to the screening of declarations of interest as well as a yearly evaluation of its revised policy on declarations of interest. It is crucial for the Agency to keep the discharge authority regularly informed on the progress achieved, and in this respect I believe that its annual activity report should include a special section describing the actions taken to prevent and manage conflicts of interest from now on."@en1
lpv:unclassifiedMetadata

Named graphs describing this resource:

1http://purl.org/linkedpolitics/rdf/English.ttl.gz
2http://purl.org/linkedpolitics/rdf/Events_and_structure.ttl.gz
3http://purl.org/linkedpolitics/rdf/spokenAs.ttl.gz

The resource appears as object in 2 triples

Context graph